Decision-Support Tool for Alzheimer's Disease

FK
Overseen ByFred Ketchum, M.D., Ph.D.
Age: 18+
Sex: Any
Trial Phase: Academic
Sponsor: University of Wisconsin, Madison
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The goal of the current study is to evaluate a decision-support tool intended to help primary care providers (PCPs) communicate with patients about blood biomarker testing for Alzheimer's Disease, enhancing shared-decision making and information sharing in the clinical space. The main questions it aims to answer are:

* Is the decision-support tool accepted and easy to use for PCPs?

* Does using the tool improve shared decision-making during clinical encounters? Researchers will compare clinical encounters between PCPs who do not use the tool to discuss blood biomarker testing for Alzheimer's Disease, versus PCPs who have been trained to utilize the tool during clinical encounters to see whether the tool effectively facilitates shared-decision making.

Who Is on the Research Team?

FK

Fred Ketchum, M.D., Ph.D.

Principal Investigator

University of Wisconsin, Madison

Are You a Good Fit for This Trial?

This trial is for adults visiting primary care who are considering blood tests to check for signs of Alzheimer's disease or memory loss. There are no specific inclusion or exclusion criteria listed.

Inclusion Criteria

Simulation 1 and Simulation 2: PCPs with experience and interest in cognitive diagnosis
I am 50 years old or older and live in the community.

Exclusion Criteria

I am 50 years old or older.
Participant exclusion: Not fluent in English
Participant exclusion: pre-existing diagnosis of cognitive impairment
See 1 more

What Are the Treatments Tested in This Trial?

Interventions

  • Shared decision-making support tool

Trial Overview

The study is testing a new decision-support tool that helps doctors and patients talk about blood biomarker testing for Alzheimer's in the clinic. Some doctors will use the tool, while others won't, to see if it improves shared decision-making.

How Is the Trial Designed?

1

Treatment groups

Experimental Treatment

Group I: Simulation clinical encountersExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Wisconsin, Madison

Lead Sponsor

Trials
1,249
Recruited
3,255,000+

National Institute on Aging (NIA)

Collaborator

Trials
1,841
Recruited
28,150,000+